We are live on ! Find out more
PTVE

Pactiv Evergreen Inc. Common stock

Delisted

PTVE was delisted on the 31st of March, 2025.

137 hedge funds and large institutions have $482M invested in Pactiv Evergreen Inc. Common stock in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 60 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $448M → $482M (+$33.6M)

4% less funds holding

Funds holding: 142137 (-5)

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

32% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 60

56% less call options, than puts

Call options by funds: $88K | Put options by funds: $200K

Holders
137
Holders Change
-5
Holders Change %
-3.52%
% of All Funds
1.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
41
Reduced
60
Closed
22
Calls
$88K
Puts
$200K
Net Calls
-$112K
Net Calls Change
-$432K
Name Holding Trade Value Shares
Change
Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
$400K -$344 -30 -0.1%
Lazard Asset Management
52
Lazard Asset Management
New York
$383K +$190K +16,550 +99%
CIC
53
Cornercap Investment Counsel
Georgia
$382K -$394K -34,310 -51%
Citigroup
54
Citigroup
New York
$362K +$238K +20,747 +194%
Ameriprise
55
Ameriprise
Minnesota
$346K -$771K -67,226 -69%
B
56
Bailard
California
$317K -$229K -20,000 -42%
Deutsche Bank
57
Deutsche Bank
Germany
$313K +$68K +5,929 +28%
EI
58
Ellevest Inc
New York
$310K -$82.5K -7,190 -21%
HCM
59
Horrell Capital Management
Arkansas
$306K -$34.2K -2,980 -10%
Manulife (Manufacturers Life Insurance)
60
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$304K -$4.07K -355 -1%
UBS Group
61
UBS Group
Switzerland
$302K +$48.4K +4,221 +19%
MIM
62
MetLife Investment Management
New Jersey
$274K
Mirae Asset Global ETFs Holdings
63
Mirae Asset Global ETFs Holdings
Hong Kong
$256K +$30.9K +2,689 +14%
CF
64
Corebridge Financial
Texas
$249K -$1.54K -134 -0.6%
Wells Fargo
65
Wells Fargo
California
$245K +$5.37K +468 +2%
Jane Street
66
Jane Street
New York
$238K -$183K -15,984 -44%
Principal Financial Group
67
Principal Financial Group
Iowa
$229K -$10.6K -926 -4%
VA
68
Vident Advisory
Georgia
$225K +$225K +19,582 New
Janus Henderson Group
69
Janus Henderson Group
United Kingdom
$224K
CCIA
70
Campbell & Co Investment Adviser
Maryland
$216K -$75.1K -6,549 -26%
Verition Fund Management
71
Verition Fund Management
Connecticut
$215K +$214K +18,656 New
CANY
72
Caxton Associates (New York)
New York
$191K -$181K -15,808 -49%
Mariner
73
Mariner
Kansas
$187K -$203K -17,691 -52%
PP
74
Paloma Partners
Connecticut
$178K +$178K +15,471 New
HBCM
75
Heron Bay Capital Management
Michigan
$178K +$177K +15,442 New

PTVE Hedge Fund Activity: Q3 2024 in Review

137 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q3 2024, worth a combined $482M — up 7.5% from $448M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of PTVE and 18 opened new positions — a net loss of 4 holders — while 60 trimmed existing stakes and 41 added.

The largest buyer was AllianceBernstein, adding an estimated $26.6M. The largest seller was American Century Companies, cutting an estimated $8.82M.

  • 137 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q3 2024, down from 142 in Q2 2024.
  • Funds reported $482M of Pactiv Evergreen Inc. Common stock stock for Q3 2024, up 7.5% quarter-over-quarter.
  • 18 funds opened new Pactiv Evergreen Inc. Common stock positions in Q3 2024 and 22 closed out, a net change of -4 holders.
  • The largest Pactiv Evergreen Inc. Common stock buyer in Q3 2024 was AllianceBernstein, an estimated $26.6M added.
  • The largest Pactiv Evergreen Inc. Common stock seller in Q3 2024 was American Century Companies, an estimated $8.82M sold.

Based on aggregated 13F filings for Q3 2024.